BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
14 results:

  • 1. Significance of Continuous Low-Dose Lenvatinib for the Treating of the Patients with Unresectable thyroid Carcinoma.
    Murakami D; Nishimoto K; Takao S; Miyamaru S; Kadowaki T; Saito H; Takeda H; Ise M; Suyama K; Orita Y
    Acta Med Okayama; 2024 Feb; 78(1):63-70. PubMed ID: 38419316
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines.
    Conroy PC; Wilhelm A; Calthorpe L; Ullmann TM; Davis S; Huang CY; Shen WT; Gosnell J; Duh QY; Roman S; Sosa JA
    Surgery; 2022 Nov; 172(5):1392-1400. PubMed ID: 36002375
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Changes in anthropometric, biochemical, oxidative, and DNA damage parameters after 3-weeks-567-kcal-hospital-controlled-VLCD in severely obese patients with BMI ≥ 35 kg m
    Ožvald I; Božičević D; Duh L; Vinković Vrček I; Domijan AM; Milić M
    Clin Nutr ESPEN; 2022 Jun; 49():319-327. PubMed ID: 35623833
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Sutton W; Crepeau PK; Canner JK; Karzai S; Segev DL; Mathur A
    Am J Surg; 2022 Jul; 224(1 Pt B):412-417. PubMed ID: 35123768
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary thyroid cancer Patients With Central Neck Metastasis?
    Han K; Noh HM; Jeong HM; Lim YC
    Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Surgical Complications and Referral Patterns in 567 Patients with Differentiated thyroid cancer in the Northern Region of the Netherlands: A Population-Based Study Towards Clinical Management Implementation.
    van Dijk D; van Dijk BAC; Weistra A; Links TP; Plukker JTM
    Ann Surg Oncol; 2020 Oct; 27(10):3872-3881. PubMed ID: 32328986
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. thyroid Lobectomy for T1b-T2 Papillary thyroid cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
    Moroney LB; Ward EC; Helios J; Crombie J; Burns CL; Blake C; Comans T; Chua B; Kenny L; Hughes BGM
    Support Care Cancer; 2020 Apr; 28(4):1867-1876. PubMed ID: 31352509
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
    Laird J; Ma J; Chau K; Chelius M; Shi W; Zhang Z; Lok BH; Yahalom J
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):670-678. PubMed ID: 29413280
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
    Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
    Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Factors associated with advanced thyroid cancer in pediatric patients in a high specialty medical unit in Northeast Mexico].
    García-Castillo LA; Bahena-García AL; Sánchez-Sánchez LM; del Carmen Palacios-Saucedo G
    Gac Med Mex; 2015; 151(6):726-30. PubMed ID: 26581530
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.
    Feng F; Wang H; Fu H; Wu S; Ye Z; Chen S; Li J
    Nucl Med Biol; 2011 Oct; 38(7):1053-8. PubMed ID: 21982575
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
    Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Thin-needle aspiration biopsy: the diagnosis of head and neck tumors revisited.
    Frable WJ; Frable MA
    Cancer; 1979 Apr; 43(4):1541-8. PubMed ID: 445350
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.